Skip to Main Content
Contribute Try STAT+ Today

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Who will pay for this drug? This is more like a ransom than business: your money or your life. The federal government (taxpayers) have already paid for the R&D through foregone taxes. I suspect the feds have also helped pay for the research directly by subsidies. They usually do. Now governments are pressured to pay for them again while CEOs make tens of millions a year and the drug companies spend more on administration and marketing than they do on R&D. When will America wake up? People are fed up being ripped off again and again. Now it’s pay for this or die.

    • Well it sounds like GcMAF to me. The FDA raided the clinics, closed them down and have now approved the product, the price has gone from £20,000 to £360,000. Criminals, they should be brought to justice.

Comments are closed.